Basic Chloroquine Information

• INN (International Nonproprietary Name): Chloroquine.

• Brand Names Available In United States: Aralen, sold as tablets 250 mg and 500 mg.

• ATC Code: P01BA01, classifying chloroquine as an antimalarial antiprotozoal agent under P01B and P01.

• Forms & Dosages: Tablets in strengths 100 mg, 150 mg, 250 mg, 500 mg; syrup/solution 50 mg/5 ml for pediatric dosing; injectable forms reported at 150 mg base/ml for limited use.

• Manufacturers In United States: Branded Aralen is known in the United States, while international suppliers include Sanofi (Nivaquine) and Ipca Laboratories; local manufacturers and generic suppliers vary by country.

• Registration Status In United States: Historic approvals exist, but use is generally confined to specific indications such as chloroquine-sensitive malaria and selected rheumatologic uses; national agencies have updated guidance after COVID-19.

• OTC / Rx Classification: Prescription Only (Rx) in nearly all countries due to toxicity and risk of misuse.

Quick Facts

Chloroquine is an antimalarial agent listed under ATC code P01BA01.

It is sold as Aralen in the United States with tablet strengths of 250 mg and 500 mg.

Pediatric syrup and injectable forms exist in some markets but availability varies by region.

Regulatory Notes

Chloroquine remains registered as an antimalarial in most malaria-endemic countries and appears on many national essential medicines lists.

Regulatory use in the EU and USA is historic and now focused on selected indications, and agencies updated recommendations after its off-label use during COVID-19.

Instructions, Warnings, And Daily-Life Integration

Important Safety First

Chloroquine is prescription-only in nearly all countries and can cause life-threatening overdose, cardiac arrhythmias, and irreversible vision damage with long-term or high-dose use.

Seek emergency care for suspected overdose; watch for arrhythmia, convulsions, or respiratory distress.

Always check national guidance and consult your prescriber before starting or changing chloroquine therapy.

Emergency checklist: call emergency services, bring medication packaging, monitor breathing and pulse, and warn responders about risk of cardiac arrhythmias.

Daily-Life Integration

Store chloroquine at room temperature between 15–25°C, protected from light and moisture, and keep it out of reach of children.

If on long-term therapy for conditions such as rheumatoid arthritis or SLE, plan regular ophthalmologic checks and inform all your healthcare providers about chloroquine use.

Do not stop long-term therapy abruptly without clinician advice because management and tapering decisions depend on the indication.

Do/Don't checklist:

• Do use a pill box, set alarms, and enroll in refill alerts to improve adherence.

• Do inform prescribers about all medicines and supplements you take, including OTCs.

• Don't double-dose if you miss one; take as soon as possible unless the next dose is near.

• Don't combine chloroquine with QT‑prolonging drugs unless under strict supervision.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Short acute malaria regimens use divided dosing over the day, for example 600 mg base initially then 300 mg base at 6, 24, and 48 hours for a total of 1.5 g base.

For chronic rheumatologic use, once-daily dosing of about 250–500 mg daily is common, and choosing the same time each day helps build a habit and reduce missed doses.

If drowsiness or mild gastrointestinal upset occurs with maintenance therapy, consider evening dosing after discussing with your prescriber.

Habit-building checklist: use a pill box, set phone alarms, and enable pharmacy refill alerts.

Taking With Or Without Meals

Chloroquine can be taken with food to reduce nausea and stomach upset, though food may modestly slow absorption.

For the fastest absorption in acute malaria, follow prescriber instructions precisely and keep to the timing schedule provided.

For pediatric syrups, measure doses with a proper oral syringe or a calibrated dosing spoon and avoid mixing with large volumes of milk that can reduce acceptance.

Administration aids and pediatric tips:

• Use a calibrated oral syringe for accuracy with 50 mg/5 ml syrup.

• Avoid household teaspoons; they are imprecise.

• Confirm the syrup concentration on the label before calculating weight-based pediatric doses.

Safety Priorities

Who Should Avoid It

Absolute contraindications include known hypersensitivity to chloroquine or related compounds, preexisting retinal or visual field changes, and a history of epilepsy.

Relative contraindications where close monitoring is needed include liver or renal impairment, psoriasis, porphyria, myasthenia gravis, and alcoholism.

Elderly patients carry greater cardiac risk and may need dose adjustments and ECG monitoring before and during therapy.

Pregnant or breastfeeding patients should follow specialist advice about risks and benefits.

Activities To Limit

Avoid driving or operating heavy machinery if you experience dizziness, blurred vision, or mood changes while taking chloroquine.

Limit alcohol because it can worsen adverse effects and interfere with monitoring of liver disease.

Dosage & Adjustments

General Regimen

Standard adult acute malaria dosing is 600 mg base initially, then 300 mg base at 6, 24, and 48 hours for a total of 1.5 g base, and prescriber confirmation is essential.

For rheumatoid arthritis or systemic lupus erythematosus, maintenance dosing typically ranges from 250 to 500 mg daily.

Pediatric acute malaria dosing is weight-based: 10 mg/kg base initially, then 5 mg/kg base at 6, 24, and 48 hours.

Special Cases

In elderly patients, use the lower end of maintenance dosing when possible and obtain a baseline ECG to check conduction and QT interval.

Patients with liver or kidney impairment often need dose reductions and closer monitoring to avoid accumulation and toxicity.

Long-term therapy requires scheduled ophthalmologic screening at baseline and periodically thereafter to detect retinopathy early.

Pediatric dosing checklist for weight-based calculation: confirm current weight, calculate initial 10 mg/kg base, then 5 mg/kg at stated intervals, and record dose clearly for caregivers.

User Testimonials

Positive Reports

Many patients treated for rheumatic conditions report improved joint pain and reduced fatigue after weeks to months on maintenance chloroquine at 250–500 mg daily.

Travelers treated for chloroquine-sensitive malaria strains describe quick symptom relief when the standard 3‑day regimen is appropriate.

Testimonials are individual experiences and depend on correct diagnosis and local parasite resistance patterns.

Common Challenges

Common complaints include nausea, headaches, and pruritus, with itching reported more frequently in some African populations.

Long-term users sometimes report vision changes, and daily dosing can challenge adherence for some patients.

Practical adherence tips include setting reminders, using pharmacy blister packs, and talking to the pharmacist about evening dosing if side effects occur.

Buying Guide

Pharmacy Sources

Chloroquine is prescription-only in most countries, and branded Aralen is available in the United States as tablets of 250 mg and 500 mg.

Generic equivalents are widely available from manufacturers such as Ipca, Sanofi (Nivaquine), and Emzor, but confirm national registries and GMP certification for suppliers.

For pediatric syrup or local formulations, always check concentration labeling such as 50 mg/5 ml and the expiration date before use.

In our online pharmacy, chloroquine is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

Prices vary by brand, country, and whether a generic option is selected, and tablets and syrups may differ significantly in per-dose cost.

Practical tips to save include comparing unit price per milligram, choosing reputable generics, using pharmacy discount cards, and checking insurance formularies.

What’s Inside & How It Works

Ingredients Overview

The active ingredient across formulations is chloroquine, presented as base or phosphate salts depending on the product and manufacturer.

Excipients vary by manufacturer, so read the package leaflet for potential allergens and consult the pharmacist if you have concerns about tablet coatings or fillers.

Sold forms include tablets (100–500 mg), syrup (50 mg/5 ml), and limited injectable preparations reported at 150 mg base/ml.

Mechanism Basics

As an antimalarial, chloroquine concentrates in parasite food vacuoles and interferes with heme polymerization, causing toxic buildup for the parasite.

For rheumatologic use, chloroquine exerts immunomodulatory effects that reduce inflammation, though the exact mechanisms are complex.

Resistance is common in many P. falciparum strains, reducing chloroquine’s usefulness in those regions and prompting artemisinin-based combination therapies as first-line choices.

• Antimalarial Action: Inhibits heme polymerization in parasites.

• Immunomodulatory Action: Reduces inflammatory activity in autoimmune conditions.

Main Indications

Approved Uses

Primary approved indications include treatment of chloroquine-sensitive malaria species and maintenance therapy for rheumatologic diseases such as rheumatoid arthritis and SLE at 250–500 mg daily.

Chloroquine appears on many National Essential Medicines Lists and the WHO Model List of Essential Medicines for its historical antimalarial role.

Regulatory status varies by country, and clinical use is now limited to selected indications and settings based on resistance and safety profiles.

Off-Label Uses

Chloroquine was used off-label during the COVID-19 pandemic, but major agencies revoked emergency use authorizations due to lack of proven benefit and safety concerns.

In areas where P. vivax remains sensitive, chloroquine may be used with primaquine for radical cure of hypnozoites under specialist guidance.

Interaction Warnings

Food Interactions

Food generally improves gastrointestinal tolerability and may modestly slow absorption of chloroquine.

There are no major food contraindications specific to chloroquine, but avoid grapefruit when taking other drugs that interact with grapefruit if advised.

For pediatric syrup, avoid mixing into very large-volume feeds to ensure the full dose is consumed.

Maintain consistent food patterns when on long-term therapy to reduce variability in absorption.

Drug Conflicts

High-risk interactions include other QT‑prolonging drugs such as certain macrolide antibiotics, some antipsychotics, and some antiarrhythmics, which can raise the risk of torsades-like arrhythmias.

Drugs that lower the seizure threshold and agents heavily cleared by liver or kidney pathways require review and possible dose adjustment.

Tell-your-prescriber checklist: provide a full medication list including OTC medicines, supplements, and herbal products before starting chloroquine.

Latest Evidence & Insights

Key Clinical Updates

Widespread P. falciparum resistance has reduced chloroquine's role in many regions, so artemisinin-based combination therapies are first-line where resistance exists.

Major regulatory agencies revoked emergency approvals for chloroquine and hydroxychloroquine during COVID-19 based on lack of efficacy and safety concerns.

Ongoing research focuses on resistance mapping and potential niche rheumatologic roles, and local malaria treatment guidelines should be consulted for current first-line therapy.

What Patients Should Know Now

If prescribed chloroquine, confirm the indication, local parasite susceptibility patterns for malaria, and the monitoring plan including ECG and ophthalmology for long-term use.

Keep in touch with your provider about side effects, and always follow local clinical guidance for malaria treatment and rheumatologic management.

• What Changed: Declining role in malaria where resistance is high and revoked emergency COVID-19 use.

• Where To Look: Follow local health authority malaria guidelines for up-to-date recommendations.

Alternative Choices

Comparable Drugs

Alternatives for malaria include artemisinin-based combination therapies, mefloquine, and primaquine for radical cure of P. vivax where indicated.

For rheumatologic disease, hydroxychloroquine is often preferred because of a more favorable safety and tolerability profile in many patients.

Each alternative has different dosing schedules and monitoring needs that should be reviewed with a clinician.

When To Switch

Switch therapy when treatment failure occurs, resistance is documented, or significant adverse effects such as retinopathy or cardiomyopathy emerge.

Before switching, assess ECG, vision, and liver and renal function, and discuss alternative regimens with a specialist or prescriber.

Regulation Snapshot

Global Regulatory Status

Chloroquine remains registered as an antimalarial in most malaria-endemic countries and appears on many national essential medicines lists and the WHO Model List.

In regions such as the EU and USA, historic approvals exist, but current clinical use is restricted to selected indications with guidance updated after COVID-19.

Manufacturer examples include Sanofi (Nivaquine), Ipca (Lariago), and Emzor Pharma, and packaging varies by country.

Prescription & Access

Almost all countries classify chloroquine as prescription-only due to its toxicity risks and potential for misuse.

For international travelers or local procurement, source chloroquine only by prescription and confirm regional resistance patterns before relying on it for prevention or treatment.

When procuring, verify national drug registers and GMP status, and use licensed pharmacies or telepharmacy services for valid prescriptions.

FAQ Section

Common Patient Questions

Q: Is chloroquine safe long-term?

A: It can be when monitored, but regular eye exams and cardiac assessments are essential because the risk of retinopathy increases with cumulative dose and duration.

Q: Can I stop chloroquine suddenly?

A: For short malaria courses, you must finish the prescribed regimen; for chronic rheumatologic therapy, consult your prescriber before stopping.

Quick Answers For Travelers And Parents

Travelers should confirm local parasite sensitivity before relying on chloroquine for therapy or prophylaxis.

Parents should use weight-based pediatric dosing and measure syrup precisely with a calibrated syringe when the concentration is 50 mg/5 ml.

• Top 10 FAQs include questions on safety, monitoring, pregnancy, missed doses, drug interactions, pediatric dosing, storage, side effects, access, and switching therapy.

• Printable travel checklist: prescription confirmation, malaria sensitivity check, full medication list, emergency contacts, and a copy of dosing calculations for pediatric use.

Guidelines For Proper Use

Practical Monitoring Checklist

Baseline assessments should include a clinical history for seizures, cardiac disease, and vision problems, plus baseline ophthalmology and ECG for those on long-term therapy.

Ongoing monitoring includes periodic vision checks, ECG when on interacting drugs or in elderly patients, and liver and renal function tests as clinically indicated.

For acute malaria, verify the dosing schedule of 600 mg base initial then 300 mg base at 6, 24, and 48 hours.

Storage, Missed Dose, And Emergency Steps

Store chloroquine at room temperature (15–25°C), protected from light and moisture, and keep it away from children to prevent accidental ingestion.

If a dose is missed, take as soon as possible unless it is almost time for the next dose and do not double doses to catch up.

Overdose is life-threatening; call emergency services immediately and watch for arrhythmias, convulsions, and respiratory distress.

Delivery Across United States